Sernova Biotherapeutics Inc
SEOVF
$0.1219
$0.00141.16%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.93M | 6.09M | 6.60M | 6.73M | 6.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.08M | 19.25M | 23.30M | 28.57M | 31.05M |
| Operating Income | -15.08M | -19.25M | -23.30M | -28.57M | -31.05M |
| Income Before Tax | -15.77M | -20.47M | -23.68M | -28.67M | -30.61M |
| Income Tax Expenses | 35.50K | 9.60K | 5.10K | -- | -- |
| Earnings from Continuing Operations | -15.81 | -20.48 | -23.69 | -28.67 | -30.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.81M | -20.48M | -23.69M | -28.67M | -30.61M |
| EBIT | -15.08M | -19.25M | -23.30M | -28.57M | -31.05M |
| EBITDA | -14.81M | -18.95M | -22.95M | -28.27M | -30.76M |
| EPS Basic | -0.05 | -0.07 | -0.08 | -0.09 | -0.10 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.05 | -0.06 | -0.06 |
| EPS Diluted | -0.05 | -0.07 | -0.08 | -0.09 | -0.10 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.05 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 1.28B | 1.25B | 1.23B | 1.21B | 1.21B |
| Average Diluted Shares Outstanding | 1.28B | 1.25B | 1.23B | 1.21B | 1.21B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |